From Yahoo Finance: 2025-04-18 11:45:00

In a recent article, eleven promising penny stocks were highlighted, with a focus on Geron Corp. (NASDAQ:GERN) and its standing among them.

On CNBC’s ‘Closing Bell,’ Solus’ Dan Greenhaus and Invesco’s Brian Levitt discussed tariffs, market uncertainty, and risk concerns. Greenhaus expressed cautious optimism, citing recent events impacting the market. Levitt highlighted potential downside risks if uncertainty persists, emphasizing the long-term investment opportunities during periods of heightened uncertainty.

A list of top penny stocks trading below $5 with high analysts’ upside potential was compiled using the Finviz stock screener, including hedge fund sentiment for each stock as of Q4 2024.

Geron Corp. (NASDAQ:GERN) is a biopharmaceutical company with a share price of $1.32 on April 15. It offers RYTELO, a telomerase inhibitor for treating lower-risk MDS. RYTELO gained US approval in 2024, with positive opinions in Europe. Analysts project a promising market for RYTELO in the US.

Ranked 5th among promising penny stocks, Geron Corp. (NASDAQ:GERN) shows growth potential. However, investing in AI stocks may offer higher returns in a shorter timeframe. Consider exploring AI stocks for potential gains.

Read more: Is Geron Corp. (NASDAQ:GERN) the Most Promising Penny Stock According to Analysts?